AKT1 and non-small cell lung carcinoma: Our investigations showed aspirin can sensitize osimertinib resistance NSCLC cells to osimertinib in vitro and in vivo by inducing apoptosis, which is dependent on inhibition of Akt/FoxO3a signaling component phosphorylation and increased Bim expression.